Advertisement

Ticarcillin Clavulanate

[17 November 2014]

Products Affected - Description

Timentin Intravenous Powder for Solution, GlaxoSmithKline
3.1 gram vial, 1 count (NDC 00029-6571-26) - discontinued
31 gram bulk package, 1 count (NDC 00029-6579-21) - discontinued
 
Timentin Intravenous Solution for Injection, Baxter
3.1 gram/100 mL frozen premixed bag, 12 count (NDC 00029-6571-31) - discontinued

Reason for the Shortage

  • GlaxoSmithKline discontinued all Timentin in November 2014.
  • GlaxoSmithKline discontinued Timentin 3.1 gram frozen, premixed bags in November 2014. Baxter distributed Timentin frozen premixed bags for GlaxoSmithKline.
  • GlaxoSmithKline discontinued Timentin 3.1 gram ADD-Vantage vials in late-2012.

Available Products

There are no products available.

Estimated Resupply Dates

GlaxoSmithKline discontinued Timentin. There are no other suppliers of ticarcillin/clavulanate injection.

Related Shortages

Updated

November 17, 2014; November 13, 2014; October 13, 2014; October 10, 2014; September 10, 2014; August 6, 2014; July 14, 2014; June 5, 2014; May 1, 2014; April 4, 2014; February 27, 2014; January 13, 2014; December 9, 2013; November 4, 2013; October 9, 2013; September 3, 2013; July 30, 2013; June 25, 2013; May 28, 2013; April 26, 2013; March 26, 2013; February 13, 2013; January 15, 2013; December 4, 2012; October 12, 2012; June 25, 2012; April 5, 2012; March 7, 2012; February 8, 2012; January 4, 2012; December 7, 2011; November 16, 2011; October 12, 2011; September 14, 2011; August 16, 2011; July 12, 2011; June 23, 2011; June 9, 2011; June 6, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement